— Know what they know.
Not Investment Advice

GCAN OTC

Trafalgar International, Inc.
1W: +2.5% 1M: +8.7% 3M: +70.5% YTD: +65.1% 1Y: -28.0% 3Y: -78.4% 5Y: -96.1%
$1.60
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · $318200 mcap · 197472 float · 0.648% daily turnover · Short 37% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +100.0% ▲
Operating Income
-$156K +10.9% ▲
Net Income
-$179K +5.0% ▲
EPS (Diluted)
$-0.00 +0.0% ▲
EBITDA
-$151K +11.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$48K$13K$0$0$0
YoY Growth+574.8%-73.7%-100.0%+0.0%+0.0%
Cost of Revenue$48K$13K$52K$5K$0
Gross Profit-$46-$25-$52K-$5K$0
Gross Margin-0.1%-0.2%———
R&D Expenses$0$0$0$0$0
SG&A Expenses$204K$151K$120K$120K$156K
Operating Expenses$294K$343K$177K$170K$156K
Operating Income-$294K-$343K-$177K-$175K-$156K
Operating Margin-612.9%-2716.9%———
Interest Expense$1M$287K$123K$13K$0
Income Before Tax-$951K-$602K-$360K-$188K-$179K
Tax Expense$0$0$0$0$0
Net Income-$3M-$510K-$544K-$188K-$179K
Net Margin-5367.4%-4036.5%———
EPS (Diluted)$-0.02$-0.00$-0.00$-0.00$-0.00
EBITDA$159K-$310K-$233K-$170K-$151K
Shares Outstanding145M490M588M755M805M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms